SCHEMBL10240316

SCHEMBL10240316

CC1(C)OC2C(CO)OC(n3cnc4c(NC5CCCC5O)ncnc43)C2O1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 6/20 0.73
ADORA3 P0DMS8 5/20 0.73
ADORA1 P30542 5/20 0.73
ADORA2B P29275 2/20 0.73
CYP2D6 P10635 1/20 0.73
PI4KA P42356 1/20 0.62
PI4K2B Q8TCG2 1/20 0.62
PI4K2A Q9BTU6 1/20 0.62
PI4KB Q9UBF8 1/20 0.62
TSHR P16473 3/20 0.55
PMP22 Q01453 2/20 0.55
GAA P10253 1/20 0.55
HTT P42858 1/20 0.55
SIGMAR1 Q99720 1/20 0.55
SLC29A1 Q99808 1/20 0.55
RXFP1 Q9HBX9 1/20 0.55
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
TP53 P04637 1/20 0.55
NFKB1 P19838 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15426678 1.00 ADORA2A (0.73) ADORA2AADORA3ADORA1ADORA2BCYP2D6
SCHEMBL9791716 1.00 ADORA2A (0.73) ADORA2AADORA3ADORA1ADORA2BCYP2D6
SCHEMBL15425667 1.00 ADORA2A (0.73) ADORA2AADORA3ADORA1ADORA2BCYP2D6
SCHEMBL13454924 0.91 PI4KA (0.62) ADORA2AADORA3ADORA1ADORA2BCYP2D6
SCHEMBL6664080 0.91 ADORA3 (0.62) ADORA2AADORA3ADORA1ADORA2BCYP2D6
SCHEMBL6664072 0.91 ADORA3 (0.62) ADORA2AADORA3ADORA1ADORA2BCYP2D6
SCHEMBL15144301 0.87 ADORA3 (0.69) ADORA2AADORA3ADORA1ADORA2BPI4KA
SCHEMBL12200089 0.87 ADORA3 (0.69) ADORA2AADORA3ADORA1ADORA2BPI4KA
SCHEMBL7735031 0.87 ADORA3 (0.69) ADORA2AADORA3ADORA1ADORA2BPI4KA
SCHEMBL5507191 0.87 ADORA3 (0.69) ADORA2AADORA3ADORA1ADORA2BPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183224-B2 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof INOTEK PHARMACEUTICALS CORPORATION (US) 2012-05-22 US disclosed
US-20090062314-A1 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof INOTEK PHARMACEUTICALS CORPORATION (US) 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062314-A1 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof ADORA2A, ADORA1, ADORA3 ADORA2A 1/4885ADORA3 3/4885ADORA1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.